Skip to main content

Want a detailed portfolio tracker?

LENZ Therapeutics (LENZ) Income Statement (2020 - 2026)

Income Statement report data from Jun 30, 2020 to Mar 31, 2026 for LENZ Therapeutics (LENZ).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020
Revenue and COGS
Total Revenue
1.90M
(+19.50%)
1.59M
(-87.28%)
13M
(+150.00%)
5.00M-------------------
Operating Expenses
Research And Development
--3.79M
(-58.17%)
9.06M
(+55.67%)
5.82M
(-0.85%)
5.87M
(-8.99%)
6.45M
(-7.19%)
6.95M
(-34.06%)
11M
(-46.06%)
20M
(+14.94%)
17M
(+34.49%)
13M
(+22.36%)
10M
(-44.04%)
18M
(+0.87%)
18M
(+2.92%)
18M
(-2.58%)
18M
(+62.80%)
11M
(+29.15%)
8.68M
(-31.49%)
13M
(+135.50%)
5.38M
(+132.90%)
2.31M
(+450.00%)
420K
Selling General And Administrative
45M
(+13.45%)
40M
(+43.59%)
28M
(+115.63%)
13M
(+15.21%)
11M
(+18.70%)
9.36M
(+44.22%)
6.49M
(-12.42%)
7.41M
(+33.51%)
5.55M
(+1.83%)
5.45M
(+90.56%)
2.86M
(+23.28%)
2.32M
(+1.31%)
2.29M
(-72.38%)
8.29M
(+5.61%)
7.85M
(-12.78%)
9.00M
(+16.73%)
7.71M
(-0.39%)
7.74M
(+30.74%)
5.92M
(+21.56%)
4.87M
(+22.06%)
3.99M
(+175.17%)
1.45M
(+66.67%)
870K
Operating Expenses
46M
(+14.96%)
40M
(+27.59%)
31M
(+43.60%)
22M
(+29.12%)
17M
(+11.16%)
15M
(+17.61%)
13M
(-9.76%)
14M
(-10.81%)
16M
(-35.61%)
25M
(+25.83%)
20M
(+32.75%)
15M
(+18.54%)
13M
(-52.82%)
27M
(+2.29%)
26M
(-2.35%)
27M
(+3.16%)
26M
(+37.06%)
19M
(+29.73%)
15M
(-16.71%)
18M
(+87.09%)
9.37M
(+149.20%)
3.76M
(+191.47%)
1.29M
Depreciation And Amortization
110K
(-56.00%)
250K--40K
(-20.00%)
50K--10K-1.59M800K
(0.00%)
800K-610K
(-12.86%)
700K
(+16.67%)
600K
(+36.36%)
440K
(+29.41%)
340K
(+70.00%)
200K
(+100.00%)
100K
(+11.11%)
90K--
Operating Income
Operating Income
-44.13M
(+14.74%)
-38.46M
(+103.60%)
-18.89M
(+12.04%)
-16.86M
(-0.41%)
-16.93M
(+11.24%)
-15.22M
(+17.62%)
-12.94M
(-9.83%)
-14.35M
(-10.81%)
-16.09M
(-35.61%)
-24.99M
(+25.83%)
-19.86M
(+32.75%)
-14.96M
(+18.54%)
-12.62M
(-52.82%)
-26.75M
(+2.29%)
-26.15M
(-2.35%)
-26.78M
(+3.16%)
-25.96M
(+37.06%)
-18.94M
(+29.73%)
-14.60M
(-16.71%)
-17.53M
(+87.09%)
-9.37M
(+149.20%)
-3.76M
(+191.47%)
-1.29M
Ebit
-44.13M
(+14.74%)
-38.46M
(+103.60%)
-18.89M
(+12.04%)
-16.86M
(-0.41%)
-16.93M
(+11.24%)
-15.22M
(+17.62%)
-12.94M
(-9.83%)
-14.35M
(-10.81%)
-16.09M
(-35.61%)
-24.99M
(+25.83%)
-19.86M
(+32.75%)
-14.96M
(+18.54%)
-12.62M
(-52.82%)
-26.75M
(+2.29%)
-26.15M
(-2.35%)
-26.78M
(+3.16%)
-25.96M
(+37.06%)
-18.94M
(+29.73%)
-14.60M
(-16.71%)
-17.53M
(+87.09%)
-9.37M
(+149.20%)
-3.76M
(+191.47%)
-1.29M
EBITDA
-44.02M
(+2.75%)
-42.84M
(+156.53%)
-16.70M
(+15.89%)
-14.41M
(-14.68%)
-16.89M
(-23.23%)
-22.00M
(+115.48%)
-10.21M
(-0.39%)
-10.25M
(-36.26%)
-16.08M
(-39.50%)
-26.58M
(+39.38%)
-19.07M
(+34.68%)
-14.16M
(+12.29%)
-12.61M
(-51.76%)
-26.14M
(+2.71%)
-25.45M
(-2.79%)
-26.18M
(+2.59%)
-25.52M
(+37.20%)
-18.60M
(+29.17%)
-14.40M
(-17.38%)
-17.43M
(+87.82%)
-9.28M
(+146.81%)
-3.76M
(+191.47%)
-1.29M
Other Income / Expenses
Interest Income
2.64M
(-11.71%)
2.99M
(+35.91%)
2.20M
(-2.22%)
2.25M
(-3.02%)
2.32M
(-9.73%)
2.57M
(-6.20%)
2.74M
(+11.38%)
2.46M
(+211.39%)
790K
(-7.06%)
850K
(-22.02%)
1.09M
(+336.00%)
250K-----------
Net Interest Income
2.64M
(-11.71%)
2.99M
(+35.91%)
2.20M
(-2.22%)
2.25M
(-3.02%)
2.32M
(-9.73%)
2.57M
(-6.20%)
2.74M
(+11.38%)
2.46M
(+211.39%)
790K
(-7.06%)
850K
(-22.02%)
1.09M
(+336.00%)
250K-----------
Other Non Operating Income
--240.00K
(+2300.00%)
-10.00K200K-10.00K290K-10.00K1.64M-1.35M90K-100.00K
(+400.00%)
-20.00K
(-60.00%)
-50.00K4.59M
(+212.24%)
1.47M
(+75.00%)
840K
(+600.00%)
120K
(+500.00%)
20K
(+100.00%)
10K--10.34M380K-20.00K
Net Income
Income Before Tax
--50.51M
(+202.46%)
-16.70M
(+15.89%)
-14.41M--29.30M
(+186.97%)
-10.21M
(-0.39%)
-10.25M--70.15M-------------
Income Tax Expense
---500K------180.00K-------------
Net Income From Continuing Operations
-41.49M
(+15.57%)
-35.90M
(+114.97%)
-16.70M
(+12.01%)
-14.91M
(+1.98%)
-14.62M
(+15.57%)
-12.65M
(+23.90%)
-10.21M
(-0.39%)
-10.25M
(-38.44%)
-16.65M
(-29.72%)
-23.69M
(+25.48%)
-18.88M
(+28.17%)
-14.73M
(+16.26%)
-12.67M
(-48.50%)
-24.60M
(-0.32%)
-24.68M
(-4.86%)
-25.94M
(+0.43%)
-25.83M
(+36.45%)
-18.93M
(+29.75%)
-14.59M
(-16.77%)
-17.53M
(-11.06%)
-19.71M
(+483.14%)
-3.38M
(+158.02%)
-1.31M
Net Income
-41.49M
(+15.57%)
-35.90M
(+114.97%)
-16.70M
(+12.01%)
-14.91M
(+1.98%)
-14.62M
(+15.57%)
-12.65M
(+23.90%)
-10.21M
(-0.39%)
-10.25M
(-38.44%)
-16.65M
(-29.72%)
-23.69M
(+25.48%)
-18.88M
(+28.17%)
-14.73M
(+16.26%)
-12.67M
(-48.50%)
-24.60M
(-0.32%)
-24.68M
(-4.86%)
-25.94M
(+0.43%)
-25.83M
(+36.45%)
-18.93M
(+29.75%)
-14.59M
(-16.77%)
-17.53M
(-11.06%)
-19.71M
(+483.14%)
-3.38M
(+158.02%)
-1.31M
Comprehensive Income Net Of Tax
-42.18M
(-48.61%)
-82.08M
(+397.15%)
-16.51M
(+10.07%)
-15.00M
(+2.11%)
-14.69M
(-70.37%)
-49.58M
(+414.85%)
-9.63M
(-6.60%)
-10.31M
(-38.08%)
-16.65M
(-76.20%)
-69.96M
(+270.75%)
-18.87M
(+28.02%)
-14.74M
(+16.34%)
-12.67M----------